Details about Anaerococcus vaginalis: NCBI 33037

Other Names: Anaerococcus sp. PH9 Anaerococcus vaginalis Anaerococcus vaginalis (Li et al. 1992) Ezaki et al. 2001 ATCC 51170 CCUG 31349 CIP 103621 DSM 7457 GIFU 12669 GIFU:12669 JCM 8138 Peptostreptococcus vaginalis Peptostreptococcus vaginalis Li et al. 1992

Change Display Name to


Does a specific lab/source detect it?
SourcePercentagesamples
SequentiaBiotech2.5641025641025643 %39
AmericanGut0 %18
uBiome34.89208633093525 %834
Thryve32.4468085106383 %376
BiomeSight30.065359477124183 %153

I want to know what End Products this bacteria produces

No information available

Possible Health Impacts

I would like to know about this bacteria's

Source:   Last Computation: 1/27/2021 9:15:00 AM

If you have multiples samples, there is a time line option, click here, pick your samples and then click [My Taxon Time Line]

🔐 From Citizen Science

Login to see more symptoms with Premium. PValue: a E-9 is stronger association then a E-5 or 0.0001

From Published Science

Based on Studies on PubMed
Medical ConditionDirectionPValue
Colorectal Cancer Low1
Type 2 Diabetes Low1

I would like to know what can change the quality that I have

You can compare microbiome impact of these by checking the desired items (try keeping the numbers below six(6) and clicking

📓 - direct citation | 👪 - Impacts Parent Taxa | 👶 - Impacts Child Taxa | 🧙 - Inferred
Search Hints: Spice | Herb | Vitamin | Probiotics | Diet | Food | Amino |Flavonoids
General Substance Specific Substance Effect
chemotherapy (prescription) chemotherapy (prescription) 📓 Increases from 2 studies

A P-value below 0.0001 is the recommended threshold. A larger R-Square valye means a stronger relationship. This is unpublished data using Properitary Artificial Intelligence.

🔐 Details about Anaerococcus vaginalis: Bacteria Interplay


Anonymous (Legacy User)